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Abstract
Enterobacteria, especially Escherichia coli, are abundant in patients with inflammatory bowel 
disease or colorectal cancer (CRC). However, it is unclear whether cancer is promoted by 
inflammation-induced expansion of E. coli and/or changes in expression of specific microbial 
genes. Here we use longitudinal (2, 12 and 20 weeks) 16S rRNA sequencing of luminal 
microbiota from ex-germ free mice to show that inflamed Il10−/− mice maintain a higher 
abundance of Enterobacteriaceae than healthy wild-type mice. Experiments with mono-colonized 
Il10−/− mice reveal that host inflammation is necessary for E. coli cancer-promoting activity. 
RNA-sequence analysis indicates significant changes in E. coli gene catalogue in Il10−/− mice, 
with changes mostly driven by adaptation to the intestinal environment. Expression of specific 
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genes present in the tumor-promoting E. coli pks island are modulated by inflammation/CRC 
development. Thus, progression of inflammation in Il10−/− mice supports Enterobacteriaceae and 
alters a small subset of microbial genes important for tumor development.
INTRODUCTION
The microbiota plays an essential role in regulating intestinal homeostasis through its 
capacity to modulate various biological activities ranging from barrier, immunity and 
metabolic function1. Not surprisingly, microbial dysbiosis is associated with numerous 
intestinal disorders including inflammatory bowel diseases (IBD) and colorectal cancer 
(CRC)2. Whether microbial dysbiosis observed in CRC patients is a consequence of the 
pathology or is a causal, active modifier of disease outcome remains to be defined. Recent 
evidence generated from experimental models indicates that microbial dysbiosis can 
influence intestinal disease, as implantation of cancer-associated biota increased cancer 
development in the azoxymethane/dextran sodium sulfate model of colitis-associated 
CRC3,4. At the taxonomic level, analysis of the human CRC microbiome has identified 
potential microbial candidates implicated in the pathology, including Enterobacteriaceae/E. 
coli and Fusobacterium5. Subsequent experiments using preclinical models of CRC have 
confirmed the carcinogenetic potential of both Fusobacterium and Enterobacteriaceae/E. 
coli6-8. While the biological events implicated in the development of microbial dysbiosis 
and emergence of carcinogenic microorganisms are yet to be defined, host genetics and 
environmental factors such as diet and lifestyle are likely contributing elements in microbial 
community assembly and maintenance9.
Chronic inflammation has been recognized as an important risk factor for numerous forms 
of cancer, including CRC10. Importantly, inflammation experienced by IBD patients is 
associated with a higher abundance of Enterobacteriaceae/E. coli in their intestinal 
microbiota11. In addition, patients with IBD and CRC displayed an increased prevalence of 
mucosal-associated E. coli compared to non-IBD and non-CRC control subjects12-15. 
Similarly, in a model of colitis-associated CRC we have previously observed a higher 
abundance of Enterobacteriaceae/E. coli in Il10−/− mice compared to Wild Type (WT) 
controls6. While high abundance of Enterobacteriaceae/E. coli appears to be a trademark of 
IBD, CRC, and mouse models of these diseases, it is still unclear if the presence of E. coli at 
high abundance is sufficient to promote carcinogenesis or whether changes in microbial 
activities are a necessary step in the pathology. For example, we and others have observed a 
high abundance of E. coli encoding the genotoxic island pks, in the intestine of IBD and 
CRC patients6,16,17 and found that pks induces double strand DNA damage in mammalian 
cells and CRC development in pre-clinical models6,18,19. Although the presence of pks 
enhances the cancer-promoting activity of E. coli NC1016, the same pks island is necessary 
for the probiotic (anti-inflammatory) activity of E. coli Nissle 191720. Therefore, it is likely 
that microbial abundance and gene activities are subjected to complex environmental 
regulation, which ultimately dictates whether the outcome for the host is beneficial or 
deleterious.
Arthur et al. Page 2













Inflammation has been mostly studied as an environmental factor affecting host physiology 
and pathology such as cancer development. While recent studies have shown that 
inflammation fosters the bloom of Enterobacteriaceae21,22, these studies mostly focused on 
the behaviour of invading microorganisms in the context of an acute inflammation. In 
contrast, the interplay between an endogenous microbial community, inflammation, and host 
pathology remains largely undefined.
To address this important question, here we longitudinally evaluate microbial community 
composition in a model of colitis-associated CRC using conventionalized Il10−/− mice (i.e. 
ex-germ free mice moved to specific pathogen free housing). In addition, we examine the 
impact of inflammation on E. coli’s carcinogenic potential using microbial RNA-seq. Our 
study indicates that inflammation reduces the strong selection pressure responsible for 
Enterobacteriaceae/E. coli decline over time. We find that inflammation is essential for E. 
coli-induced CRC in Il10-deficient mice, as the pathology is not observed in inflammation-
resistant Il10−/−;Rag2−/− mice. Evaluating the E. coli transcriptome reveals, surprisingly, 
that E. coli gene expression is most strongly influenced by colonization of the mammalian 
intestine over time, with only a minimal repertoire of genes influenced by inflammation/
cancer, among them the genotoxic island pks. This study demonstrates the dynamic and 
complex response of commensal microbes to host environmental factors, and illustrates the 
key role of inflammation in promoting E. coli-associated cancer activity.
Results
Microbial assembly changes over time in Il10−/− vs WT mice
We had previously observed alterations to the microbiota of Il10−/− mice at 20 weeks post-
conventionalization, a time corresponding to development of colitis-associated CRC6. To 
examine the timeline of microbial changes during development of colitis-associated CRC, 
we longitudinally collected stools from Il10−/− and WT mice at 2 weeks, 12 weeks and 20 
weeks after conventionalization and performed phylogenic studies. In these experiments, 
mice were allowed to acquire the microbial community from their cage 
microenvironment6,23. To assess the effects of genotype and time on microbial community 
assembly, we performed Principal Co-ordinate Analysis (PCoA) using Bray-Curtis 
dissimilarity at the Operational Taxonomic Unit (OTU) level. We utilized Analysis of 
Similarity (ANOSIM), nested on cage to correct for observed cage effects6,23, to compare 
overall microbial community composition. At all time-points, the microbial community of 
Il10−/− colitis-susceptible mice differed significantly from that of healthy WT mice (Fig. 1a, 
Supplementary Fig. 1). We observed a dramatic shift in both WT and Il10−/− microbial 
communities from 2 to 12 weeks and 2 to 20 weeks (Fig. 1a). The WT community structure 
appears to stabilize earlier than the Il10−/−community, as a significant difference is observed 
in Il10−/− but not WT animals from 12 to 20 weeks (Fig. 1a-c). As inflammation in SPF 
Il10−/− mice progresses from an average score of 1 at 2 weeks to a score of 2.25 at 12 weeks 
and over 3 at 20 weeks6, we attribute this differential community structure to the presence of 
inflammation in Il10−/− mice. Our mixed linear model (See Methods and McCafferty et al23) 
revealed that time and time×genotype interactions are strongly associated with the structure 
of the microbial community in our experiment while genotype displays a smaller but still 
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significant association (Fig. 1d). Similarly, differences in microbial richness between the 
Il10−/− and WT microbiota became more pronounced over time, with inflammation driving 
statistically significant differences in the communities at the three time-points (Fig. 1e and f, 
Supplementary Fig. 1). Thus host genotype (inflammation) and time both appear to 
influence the assembly of the microbial community.
Early abundance of Proteobacteria in Il10−/− mice
We and others have observed an increased abundance of Proteobacteria, in particular 
Enterobacteriaceae and E. coli, associated with IBD and CRC in mice and humans6,12,13,15. 
Therefore, we hypothesized that host-initiated inflammation promotes abundance of 
Proteobacteria/Enterobacteriacaeae/E. coli, which then supports further inflammation/
tumorigenesis. We assessed the phylum level abundance of the luminal microbiota at 2, 12, 
and 20 weeks post-conventionalization. Surprisingly, the abundance of Proteobacteria 
declined over time as inflammation increases in Il10−/− mice, although levels are 
consistently and significantly higher at all time-points than in WT mice (Supplementary Fig. 
2 and 3). A similar phenomenon is observed in WT mice where Proteobacteria declined over 
time, indicating a natural selection against this phylum over time. In addition, WT mice also 
exhibited a greater abundance of Bacteroidetes at 2 weeks and a lower abundance of 
Verrucomicrobia at 12 and 20 weeks, relative to Il10−/− mice (Supplementary Fig. 3, 
Supplementary Data 1). We next assessed the family-level distribution of the microbiota and 
found that the family Enterobacteriaceae declined over time in both groups, but was 
significantly more abundant in Il10−/− relative to WT mice at all time-points (Fig. 2a, 
Supplementary Data 2). At the OTU level, Consensus 27, which represents the genera 
Escherichia/Shigella (99% certainty by RDP), displayed a similar pattern of higher 
abundance in Il10−/− mice compared to WT, but also declined over time (Fig. 2b). These 
data demonstrate similarities in the effect of time on the assembly of the microbiota in both 
WT and Il10−/− mice, where there is a shift in community structure over time from an early 
Firmicutes dominated community with more Proteobacteria to a community more 
dominated by Firmicutes and Bacteriodetes with fewer Proteobacteria (Supplementary Fig. 
3). Thus Proteobacteria/Enterobactericeae/E. coli abundance changes with succession and 
does not correlate with the progression of inflammation over time. Nonetheless, the 
abundance of Proteobacteria/Enterobacteriaceae/E. coli is consistently higher in colitis/
cancer-susceptible Il10−/− mice, relative to WT mice, at all time-points (Fig. 2).
The intestinal E. coli NC101 transcriptome changes over time
Having observed that progression of inflammation does not necessarily induce an increase in 
Enterobacteriaceae abundance, we sought to identify a mechanism by which inflammation is 
essential for the cancer-promoting activity of E. coli NC101 in AOM/Il10−/− mice. We 
hypothesized that host-initiated intestinal inflammation alters the transcriptional repertoire 
of E. coli genes that may impact carcinogenesis. We tested this hypothesis by mono-
associating germ-free mice with E. coli NC101. In this experimental model, absence of 
competing microorganisms allows E. coli to maintain a stable niche over time6. We then 
used microbial RNA sequencing (RNA-seq) to evaluate the E. coli transcriptome in stool 
samples collected over the course of inflammation and tumorigenesis in AOM/Il10−/− mice 
(2 days, 12 weeks and 18 weeks post mono-association). A Principal Component Analysis 
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plot from the normalized counts of all samples and time points revealed a remarkable 
clustering of the E. coli transcriptome during the progression of inflammation over time 
(Fig. 3a). Numerous genes were differentially expressed (DE) over time (207 from 2 days 
vs. 12 weeks and 1420 from 2 days vs. 18 weeks, FDR-corrected P<0.10) and mapping 
these genes to KEGG pathways using Pathview24 revealed the majority belong to general 
metabolic pathways (Fig. 3b). From these experimental results, we concluded that these 
transcriptomic changes over time may be due to the progression of inflammation from 2 
days to 18 weeks or simply represent normal adaptation to the intestinal niche.
E. coli requires inflammation to promote AOM-initiated CRC
RNA-seq analysis revealed substantial changes to the E. coli transcriptome over the time of 
intestinal colonization in Il10−/− mice (Fig. 3), but it was unclear if these changes were due 
to inflammation/cancer or adaptation to the mammalian intestine (i.e. colonization time). 
Moreover, the functional implication for these E. coli transcriptional responses in mediating 
this carcinogenic effect was unclear. To determine what changes in the E. coli transcriptome 
are induced by inflammation and may impact the development of CRC, we used 
Il10−/−;Rag2−/− mice that lack functional T and B cells, essential cellular components for 
development of chronic colitis25. One cohort of Il10−/− mice was not injected with AOM in 
order to evaluate the pro-carcinogenic effect of E. coli NC101 in the absence of initiation by 
a carcinogen. Histological analysis revealed high levels of inflammation that did not differ 
between AOM/Il10−/− and Il10−/− mice, but a complete absence of inflammation in AOM/
Il10−/−;Rag2−/− mice at 20 weeks post-colonization (Fig. 4a). The number of macroscopic 
tumors was higher in AOM/Il10−/− vs. Il10−/− mice, and invasive tumors (neoplasia score of 
4 or 5) were only detected in AOM-treated animals (Fig. 4b and c), supporting our earlier 
observations6 that E. coli NC101 rarely induces invasive tumors in Il10−/− mice in the time 
frame tested. Both AOM/Il10−/− and Il10−/− mice exhibited a significantly higher tumor 
burden than AOM/Il10−/−;Rag2−/− mice (Fig. 4b). In these 9 non-inflamed AOM/
Il10−/−;Rag2−/− mice, 4 exhibited no macroscopic tumors, and 5 exhibited 1 non-invasive 
macroscopic tumor each. In agreement with histological inflammation, expression of 
inflammatory cytokines was lower in AOM/Il10−/−;Rag2−/− vs. AOM/Il10−/− or Il10−/− 
mice (Supplementary Fig. 4). Fecal E. coli load did not differ between AOM/
Il10−/−;Rag2−/−, AOM/Il10−/− or Il10−/− mice, as measured by 16S PCR analysis, 
suggesting that low inflammation and tumor loads in AOM/Il10−/−;Rag2−/− mice are not 
due to fluctuation in E. coli NC101 abundance (Fig. 4d). These data demonstrate that the 
sole presence of E. coli is not sufficient to induce CRC in Il10−/− mice and that 
inflammation is essential to the tumorigenic process.
Colonization over time shapes the gut E. coli transcriptome
Although we observed substantial changes in the E. coli transcriptome over time in mono-
associated AOM/Il10−/− mice (Fig. 3), this transcriptional response could be due to either 
microbial adaptation or inflammation. To control for the effects of time (adaptation), 
independent of inflammation, we performed microbial RNA-seq analysis on longitudinally-
collected stool samples from germ-free mice mono-associated with E. coli NC101 with 
inflammation (Il10−/−), inflammation/CRC (AOM/Il10−/−), and no inflammation/CRC 
(AOM/Il10−/−;Rag2−/−) at 2, 12, 20 weeks post-colonization (Fig. 5a). These time points 
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were selected based upon previous observations regarding the development of inflammation 
(minimal at 2 weeks) and cancer (pre-cancer at 12 weeks, cancer at 20 weeks) in these mice 
as described above (Fig. 1). To assess the effects of inflammation/genotype and time of 
colonization on the E. coli transcriptome, we first generated a Principal Component Analysis 
plot from the normalized gene counts of all the samples and time points. Surprisingly, the E. 
coli transcriptome clustered predominantly by time of colonization, rather than 
inflammation/genotype (Fig. 5b). This revealed time to be the most significant factor 
affecting the E. coli transcriptome. We next compared differential gene expression over time 
between and within each disease group to evaluate E. coli transcriptome changes during 
adaptation to colonizing the mammalian intestine. We found there were 568-1000 DE genes 
within each disease group between 2 and 12 weeks post-colonization and 995-1233 DE 
genes between 2 and 20 weeks. To determine which changes in gene expression occurred in 
response to colonization regardless of host genotype/disease, we identified the differentially 
expressed genes common among all three disease groups and found 272 DE genes between 
2 and 12 weeks, and 465 DE genes between 2 and 20 weeks (Supplementary Data 3). 
Mapping these genes to KEGG pathways revealed that the majority belong to general 
metabolic pathways (Supplementary Fig. 5). These data suggest that E. coli adaptation to the 
mammalian intestine induces significant changes to the microbial transcriptome.
The pks genes are differentially expressed by cancer status
Mono-association experiments indicated that inflammation is necessary for E. coli NC101-
enhanced tumorigenesis in AOM-initiated Il10−/− mice (Fig. 4), which led us to evaluate the 
effect of inflammation on the E. coli NC101 transcriptome. In this evaluation, we compared 
gene expression between AOM/Il10−/−;Rag2−/− (no colitis/baseline reference) vs. Il10−/− 
(colitis) and vs. AOM/Il10−/− (colitis/CRC) mice. Surprisingly, few genes were 
differentially expressed in either of these comparisons at any time point (Fig. 5c; 
Supplementary Data 4). We next evaluated the effect of cancer on the E. coli transcriptome 
by comparing gene expression between Il10−/− mice (colitis) vs. AOM/Il10−/− mice (colitis/
CRC). We found that the differential expression of 66 E. coli genes is driven by cancer 
status at 12 weeks (dysplasia/pre-cancer6) and 20 weeks post-colonization (cancer), with 11 
of these genes shared among both time points (Fig. 5d; Supplementary Data 5). These 
differences were unlikely to be caused by AOM treatment alone, as these genes were not 
differentially expressed between Il10−/− and AOM/Il10−/−;Rag2−/− mice at 12 or 20 weeks. 
This suggests that the cancer microenvironment may impact the functional potential of E. 
coli to promote cancer progression.
We have previously shown that disruption of a single gene island, the pks pathogenicity 
island, can influence the development of cancer in AOM/Il10−/− mice6. Five pks island 
genes (ClbG, ClbH, ClbL, ClbM, ClbN, Supplementary Data 5) were among 66 genes 
significantly impacted by cancer (i.e. they were DE between Il10−/− and AOM/Il10−/−) at 12 
weeks (P < 10−5 Fisher exact test for the null hypothesis that 5 pks island genes could have 
been chosen by chance among the 66 DE genes). We used operon based differential 
expression analysis (see Methods) between Il10−/− and AOM/Il10−/− to identify E. coli 
operons that respond to cancer (Supplementary Data 6). This approach identified the pks 
island as among the top five operons significantly up-regulated (out of 448) in AOM/Il10−/− 
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compared to Il10−/− at 12 weeks time-point (FDR-corrected P < 0.05). The other four 
operons identified among the top five differentially expressed are ribosomal proteins 
implicated in housekeeping functions (Supplementary Data 6). Supplementary Figure 6a 
depicts operons differentially expressed on the E. coli NC101 genome and showed the pks 
island to be one of the most significant responding operons at 12 weeks. At 20 weeks, when 
cancer has developed, AOM/Il10−/− mice show less differential expression of genes in the 
pks operon (19th most differentially expressed, FDR-corrected P=0.73; Supplementary 
Figure 6, right panel). This suggests that changes to the intestinal microenvironment during 
cancer development may maintain or enhance pks transcription and carcinogenesis/
tumorigenesis in carriers of pks+ E. coli. Overall, our findings highlight the complex 
interaction between host inflammation and microbial composition/activity in the 
development of colitis-associated CRC.
Discussion
We previously reported that intestinal inflammation was not sufficient to promote CRC in 
Il10−/− mice and that specific microbial activities such as those generated by E. coli pks are 
essential for tumorigenesis6. Interestingly, genetic deletion of pks attenuated development of 
invasive tumors without impacting the colitogenic potential of E. coli, suggesting an 
uncoupling process between inflammation and carcinogenesis. In this study, we investigated 
in more detail the relationship between intestinal inflammation and microbial-induced 
carcinogenic ability. Our work suggests a nuanced relationship between E. coli and 
inflammation. First, we observed that developing inflammation in Il10−/− mice is not 
promoting an expansion of the Enterobacteriaceae/E. coli niche over time, but rather 
antagonizes the natural negative selection of this bacterial group23,26-28. This observation is 
not related to the use of conventionally-derived mice, since conventionally-raised Tlr5−/− 
mice inoculated with E. coli LF82 also exhibited reduced E. coli abundance over time, but 
still maintained higher levels than non-inflamed mice29. Natural negative selection of 
Proteobacteria is also less efficient in the intestine of human babies with late onset sepsis 
than in healthy controls30. The mechanisms by which E. coli resists negative selection in the 
inflamed intestinal environment are unclear. A recent report22 suggested that nitrate 
production derived from host inducible nitric oxide synthase (iNOS) fosters the bloom of 
Enterobacteriaceae. Our observation that there is no correlation between iNOS gene 
expression and E. coli load, coupled with the protective effect of iNOS in colitis-associated 
CRC31 suggest a more complex interaction between host inflammation, bacteria and tumor 
development.
To determine if the cancer risk introduced by E. coli is dependent on inflammation, we 
mono-associated inflammation susceptible AOM/Il10−/− and inflammation-resistant AOM/
Il10−/−;Rag2−/− mice with E. coli NC101 and found that a high abundance of E. coli was not 
sufficient for tumorigenesis in the absence of inflammation. This minimal and non-invasive 
tumorigenesis is not simply inherent to the Rag2−/− genotype, as Rag2−/− mice develop 
intestinal cancer in response to other stimuli, including the Epsilon-Proteobacteria 
Helicobacter hepaticus and carcinogen methylcholanthrene32,33. As E. coli loads were 
equivalent in inflamed AOM/Il10−/− and non-inflamed AOM/Il10−/−;Rag2−/− mice, the lack 
of CRC cannot be attributed to a failure to colonize Il10−/−;Rag2−/− mice. Rather, we 
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interpret these findings as meaning that specific environmental conditions (e.g 
inflammation), in addition to presence of E. coli, are necessary for development of CRC in 
Il10−/− mice.
We hypothesized that inflammation may alter the gene expression of E. coli during intestinal 
colonization. However, RNA-seq analysis on longitudinally-collected stool samples from 
inflamed (Il10−/− and AOM/Il10−/−) and non-inflamed (AOM/Il10−/−;Rag2−/−) mice 
revealed numerous differentially expressed genes and a remarkable clustering of the E. coli 
transcriptome by time. Thus microbial adaptation to the mammalian intestine over time – 
and not mouse genotype and disease phenotype – is a dominant force shaping the intestinal 
E. coli transcriptome. These results highlight the importance of controlling for the effects of 
time as well as health and disease phenotypes in order to reach sound conclusions in 
microbiome studies.
Inflammation alters a surprisingly small number of genes at 12 weeks, which account for 
less than 0.5% of total E. coli genes and virtually no genes (<0.01%) at 20 weeks. It is 
notable that virtually no gene expression changes are apparent at 20 weeks post-
colonization, which may indicate that the E. coli transcriptome has adapted to the inflamed 
intestine after this extended period of colonization. The small number of microbial genes 
(17-21) regulated by inflammation at 12 weeks sharply contrasts with the 568-1233 DE 
genes within each genotype/disease compared across time-points. We conclude that at the 
time points examined in this current study, inflammation minimally impacts E. coli gene 
expression. Previously, Patwa et al.34 concluded that inflammation impacts expression of 
numerous E. coli genes, which contrasts with our current findings. This could be due to 
profound differences in experimental approach, such as technology (microarray vs. RNA-
seq), non-inflamed genotype control (WT vs. Il10−/−;Rag2−/−), sampling location (cecal vs. 
fecal) and observation time (single end point vs. multiple time points). These mono-
association studies may not fully reflect E. coli behaviour in a human host harbouring a 
naturally acquired complex microbial community. Future studies will determine E. coli 
transcriptomic response in presence of a complex microbiota.
We detected 66 DE genes at both 12 and 20 weeks post-colonization in Il10−/− vs. AOM/
Il10−/− mice, with 11 DE genes represented at both time-points throughout the progression 
of cancer. While it is currently unclear if these changes are a cause or consequence of cancer 
development, future functional studies employing microbial gene knockouts and gnotobiotic 
approaches will address the importance of these 11 genes. Indeed our previous work 
demonstrated that deletion of a single microbial gene cluster, the pks pathogenicity island, 
can impact the incidence and severity of CRC in E. coli NC101 mono-associated AOM/
Il10−/− mice6. The critical role of pks in promoting CRC was recently confirmed in another 
experimental model30. However, there is no data about the transcriptional regulation of the 
pks island in vivo during the course of inflammation/cancer. Our data show for the first time 
that the pks island is significantly responsive to the inflammatory/carcinogenic environment 
in Il10−/− mice. Whether other strains harboring the pks island respond similarly to the 
inflammatory and carcinogenic environment will require further experiments. At this time, 
no methods exist to detect the bioactive product of the pks island, colibactin, as its precise 
structure is unknown, so it is unclear how expression of pks genes relates to the production 
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and cancer-promoting activity of this genotoxin. Nonetheless, maintained expression of 
genes with cancer-promoting activities could reasonably impact the progression of CRC.
In addition to transcriptional response, additional mechanisms could contribute to or modify 
E. coli carcinogenic potential. For example, many E. coli functions involved in virulence 
and colonization are a consequence of post-transcriptional regulation (i.e. two-component 
systems35,36, nucleotide- and small molecule- based second messengers37,38 etc.). 
Proteomics analysis of E. coli NC101 suggest minimal changes during inflammation39. 
Therefore it will be important to evaluate the E. coli metabolome in response to 
inflammation and cancer as metabolomics technologies become better developed and more 
affordable. Another possible mechanism to be investigated is inflammation-induced loss of 
protective mucins and increased epithelial access40,41, which can enhance the ability of E. 
coli to interact with the host epithelium. Defective Muc2 expression in Il10−/− mice has been 
shown to facilitate bacterial access to the epithelium40,42. In this scenario, inflammation 
would not significantly alter the functional capabilities of E. coli, but would poise it at a 
unique location with unfettered access to deliver bacterial products to host epithelial cells 
and impact inflammation and carcinogenesis. This mechanism would be consistent with our 
observation that non-inflamed AOM/Il10−/−;Rag2−/− mice fail to develop CRC, despite a 
high abundance of luminal E. coli.
In conclusion, we have found that inflammation does not promote an observable increase in 
E. coli abundance in the luminal compartment, but may enhance E. coli resilience in the 
intestine. Although inflammation did not drive substantial changes in the E. coli 
transcriptome, inflammation was critical for tumor development, perhaps by maintaining 
expression of selected pks-associated genes. These findings highlight the complex interplay 
between inflammation, microbial activity and cancer development. Future studies will 




All animal protocols were approved by the Institutional Animal Care and Use Committee of 
the University of North Carolina at Chapel Hill.
Azoxymethane (AOM)/Il10−/− model
Interleukin-10 (Il10)-deficient, Il10; Recombination activating gene 2 (Rag2) double-
deficient, and WT 129/SvEv mice were born and raised in germ-free isolators until either the 
day they were transferred to SPF facility (SPF model) or mono-associated with E. coli 
NC101 (mono-association model) for the immediate initiation of CRC experiments. In SPF 
experiments, mice were colonized by naturally acquiring the microbiota from their cage/
room microenvironment upon transfer from GF to SPF conditions. This approach negates 
confounding factors of familial and maternal transmission of the microbiota that can be 
experienced in mice born and raised in SPF conditions23,43. Because AOM treatment had no 
effect on the microbiota assessed at 20 weeks in the previous study6 (P=1 using both 
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ANOSIM and PERMANOVA to evaluate the null hypothesis that AOM does not contribute 
to microbial community composition in this dataset), we did not distinguish between AOM 
treatment groups in testing hypotheses on the state of the microbial community. For the 
mono-association model, GF mice were transferred to a gnotobiotic isolator and colonized 
with E. coli NC101 by gavage and rectal swabbing44. They remained in this isolator 
throughout the study. In all experiments, male and female mice were aged 7-12 weeks at 
initiation of these experiments and housed 2-4 mice per cage. Four weeks after colonization, 
mice received 6 weekly i.p. injections of AOM (10 mg/kg). Stool was collected throughout 
the experiments at 2, 12, and 20 weeks. Mice were sacrificed at 20 weeks, stool and tissue 
were collected, and colons were examined macroscopically for tumors and then swiss-rolled 
and fixed in formalin for paraffin embedding and histology44. Histology was scored for 
inflammation45 and dysplasia/tumors6 by two blinded experienced investigators. Dysplasia 
was scored as follows, taking into account the entire colon section and not simply the most 
severe lesion: 0 = no dysplasia, 1 = mild dysplasia characterized as aberrant crypt foci 
(ACF), +0.5 for multiples, 2 = moderate dysplasia characterized as gastrointestinal neoplasia 
(GIN), +0.5 for multiples, 3 = severe or high grade dysplasia characterized as adenoma, 
restricted to the mucosa, 4 = invasive adenocarcinoma, invading into or through the 
muscularis mucosa, 5 = fully invasive adenocarcinoma, full invasion through the submucosa 
and into or through the muscularis propria6.
Animal cohorts
Three animal cohorts were used in this manuscript. The first cohort was utilized for 
longitudinal sequencing of the fecal microbiota and is described above as the SPF model. 
16S data from the 20 weeks time-point were previously published6. The longitudinal 
assessment including 2 and 12 weeks time-points of this cohort are published for the first 
time here (Fig. 1-2). Two additional cohorts, mono-associated with E. coli NC101, were 
used for RNA-seq and are described for the first time here. One cohort included only AOM/
Il10−/− mice, with stools from 2 days, 12 weeks and 18 weeks post mono-association used 
for RNA-seq (Fig. 3). An additional cohort included Il10−/−, AOM/Il10−/−, and AOM/
Il10−/−;Rag2−/− mice, with stool samples collected at 2, 12 and 20 weeks post mono-
association. In this cohort, cancer and inflammation were assessed (Fig. 4) and RNA-seq 
was used to evaluate the E. coli transcriptome (Fig. 5).
DNA extraction
Stool samples were collected from SPF mice to assess luminal microbiota. Colon biopsies 
(2×10 mm) were collected after flushing the colon with PBS. Samples were immediately 
stored at −80 °C. DNA was extracted from between 50-200mg of stool or 100 mg colon 
tissue as described in6,44.
Bacterial quantitative qPCR
Bacterial qPCR was performed on total DNA extracted from stool at the 20 weeks time-
point of each experiment as described previously6. Briefly, amplification was performed in 
triplicate with SYBR green qPCR chemistry according to manufacturer’s protocol (Applied 
Biosystems) using the following primers: E. coli 16S rRNA F 5’- 
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CATGCCGCGTGTATGAAGAA-3’, E. coli 16S rRNA R 5’- 
CGGGTAACGTCAATGAGCAAA-3’, universal 16S rRNA F 5’- 
GTGSTGCAYGGYTGTCGTCA-3’, universal 16S rRNA R 5’- 
ACGTCRTCCMCACCTTCC C-3’6. CT values from E. coli were normalized to 16S to 
generate ΔCT values. E. coli load was calculated by comparing CT values to a standard 
curve from known concentrations of cultured E. coli NC101.
qPCR for host cytokine expression
To assess host cytokine expression, RNA was extracted from distal colon biopsies using 
TRIzol (Invitrogen) and cDNA was reverse transcribed using Moloney murine leukemia 
virus (MMLV; Invitrogen) according to manufacturer instructions. qPCR amplification was 
performed in triplicate with SYBR green qPCR chemistry (Applied Biosystems) using 
primers for Nos2 (F-5’- GTGGTGACAAGCACATTTGG-3’, R-5’- 
GGCTGGACTTTTCACTCTGC-3’), Il1b (F-5’- GCCCATCCTCTGTGACTCAT-3’, R-5’- 
AGGCCACAGGTATTTTGTCG-3’), Ifng(F-5’- CTTCCTCATGGCTGTTTCTGG-3’, 
R-5’- ACGCTTATGTTGTTGCTGATGG-3’), Il12b (5’- 
GGAAGCACGGCAGCAGCAGAATA-3’ and 5’- 
AACTTGAGGGAGAAGTAGGAATGG-3’), and Gapdh (F-5’- 
GGTGAAGGTCGGAGTCAACGGA -3’, R-5’- GAGGGATCTCGCTCCTGGAAGA -3’) 
on an ABI 7900HT Fast Real-Time PCR System. CT values were normalized to Gapdh to 
generate ΔCT values, and fold changes were calculated by ΔΔ CT to the mean ΔCT of the 
AOM/Il10−/−;Rag2−/− group.
Illumina V6 16S library construction and sequencing
The V6 hypervariable region of the 16S rRNA gene was amplified using a two-step PCR 
strategy6. The first step uses primers to the V6 region of the 16S rRNA gene that contain a 
4-6 nucleotide barcode for multiplexing6. The subsequent PCR adds Illumina paired-end 
sequencing adapters and a flow-cell adapter on the 5’ and 3’ ends of the amplicon. 
Amplicons were visualized on 1.5% agarose gel and purified using the QIAquick PCR 
purification kit (Qiagen). 50ng of DNA from each sample was pooled to a final 
concentration of 29 ng/ul and subjected to paired-end Illumina HiSeq2000 sequencing at the 
University of North Carolina High Throughput Sequencing Facility.
A total of 230,348,938 paired-end reads were generated using two lanes of Illumina 
HISeq2000 for a total of 244 samples. Requiring a minimum of 70 continuous matching 
nucleotides between the forward and the reverse reads, we generated 40,400,733 consensus 
sequences for the current study representing 118 samples. Those sequences were processed 
as described previously6,23. AbundantOTU+ v.0.93b (http://omics.informatics.indiana.edu/
AbundantOTU/otu+.php) with the “-abundantonly” option was used to cluster those 
sequences into 2,273 Operational Taxonomic Units (OTUs) incorporating 99.68% of the 
total input sequences. UCHIME (http://www.drive5.com/uchime/46) and the Gold reference 
database were used to screen for the presence of chimeras in our OTU sequences and a total 
of 20 OTUs were removed. The remaining 2,253 OTUs (representing 99.63% of the input 
sequences) were used for downstream analysis. Taxonomic assignments were done using 
BLASTn (v. 2.2.28+47) with an expectation value threshold of e-5 to map the OTU 
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sequences to the Silva database (release 108, http://www.arb-silva.de/). After that, we 
utilized the standalone version of the RDP (Ribosomal Database Project) classifier (v.2.548) 
to classify the full-length Silva sequences with the best BLASTn match to the OTU 
sequence requiring an RDP confidence score of ≥80%. Microbial richness was calculated as 
the number of distinct OTUs present in each sample or each cage (median of all samples 
from a particular cage) after rarefying to 15,859 sequences/sample or 56,202 sequences/
cage.
Pivot tables for the OTU, Phylum, Class, Order, Family and Genus were generated as 
described previously23. We used a mixed linear model utilizing SAS software to analyze the 
data and accounting for possible contributions that may arise from co-housing the mice in 
the same cage23. In Fig. 1e and 2, the median value of each cage is shown for visualization 
purposes. In Fig. 1f and 2, however, P-values are reported from our mixed linear model 
using F-test, which accounts for the contribution of cage. A parallel analysis using QIIME v.
1.7.049 was also conducted, utilizing both de novo (at 97% similarity level) and close-
reference OTU picking approaches (at 97% similarity level using the Greengenes 97% 
reference dataset, release of May 2013). This analysis yielded broadly similar results 
(Supplementary Fig. 1).
Bacteria RNA isolation
Stool samples were longitudinally collected from Il10−/− mice at 2 days, 12 weeks and 18 
weeks (Fig. 3) or from Il10−/−, AOM/Il10−/−, and AOM/Il10−/−;Rag2−/− mice at 2, 12 and 
20 weeks post mono-colonization (Fig. 5-6) to isolate bacterial mRNA. Stool samples were 
snap frozen and stored at −80°C. RNA was extracted from between 50-200mg of stool as 
follows. Total bacterial RNA was isolated from stool using RiboPure Bacteria Kit (Ambion, 
Austin, TX) and depleted of ribosomal and transfer RNA using MicrobeExpress (Ambion, 
Austin, TX). Before preparation of double stranded cDNA (see below), bacterial DNA 
contamination was assessed by performing a 50 cycle PCR reaction using 100ng of RNA as 
a template with the following primers to detect pks island genes6,50: clbB forward 5’- 
GCGCATCCTCAAGAGTAAATA-3’ and reverse 5’- GCGCTCTATGCTCATCAAC-3’ 
(PCR-product size = 283bp) and clbN forward 5’- GCAGCGCAAAATACCATAAAT -3’ 
and reverse 5’- TGGGCTGTTGGATTTAGTCAC-3’ (PCR-product size = 331bp). Absence 
of both bands was required to proceed with the preparation of the double stranded cDNA. A 
cDNA library was constructed using TruSeq™ RNA Sample Prep Kit v2 (Illumina, 
Hayward, CA). A PCR reaction for clbB and clbN expression was performed (30 cycles) to 
confirm the presence of these genes on our samples. For the first RNA-seq experiment (Fig. 
3) 10 samples were multiplexed into 1 lane and for the second RNA-seq experiment (Fig. 5) 
35 samples were spread into 3 lanes for paired end sequencing. One sample from the second 
RNA-seq experiment could not be assigned to any mouse and therefore was excluded from 
the analysis.
Illumina RNA-seq
Our first RNA-seq experiment (AOM/Il10−/−, Fig. 3) generated 151,331,485 paired-end 
reads 100 bases long for a total of 10 samples. The second RNA-seq experiment (Fig. 5-6) 
generated a total 542,090,141 paired-end reads 100 bases long for a total of 35 samples. 
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PCA plots revealed no batch effect by lane (Supplementary Fig 7). A QC/QA approach 
similar to that described by Castellarin et al.51 was adopted from human to mouse-
associated samples to clean and filter the reads. Briefly, all reads were mapped to the UCSC 
mouse genome (mm19) sequences using Novoalign v.2.08.03 (NovoCraft Technologies, 
Selangor, Malaysia). Reads that mapped to the mouse genome were excluded from further 
analysis. A re-analysis of the data based on Bowtie252 v. 2.2.1 alignments led to nearly 
identical results. We screened RNA-seq data for the presence of bacteria other than 
Escherichia using MetaPhlAn53 v. 1.7.3 and found that 100% of the reads were assigned to 
Escherichia except for 3 of 35 samples showing 84%, 93%, and 97% of reads assigned to 
Escherichia. These minority reads were assigned to species that are common contaminants 
on sequencing equipment: 16% (Staphylococcus), 7% (Staphylococcus) and 3% 
(Pseudomonas). These data confirm that Il10−/− mice were only colonized with E. coli.
To enhance the available draft genome of E. coli NC101 (NCBI GenBank accession 
AEFA00000000.1), we utilized reads from the first RNA-seq experiment along with the 
original Roche 454 sequences that were used to produce the AEFA00000000.1 assembly. 
The concept of enhancing genome assembly using RNA-seq data has been successfully 
applied to Caenorhabditis54 The RNA-seq reads, from the first RNA-seq experiment, that 
were utilized in the genome assembly process were first cleansed (see above) and filtered at 
Q20, followed by merging overlapping reads using FLASH55. Both the merged and 
unmerged reads were subjected to digital normalization56 then fed into Newbler genome 
assembler (v.2.6 20110517_150257) along with the Roche 454 shotgun sequences. The 
hybrid assembly reduced the total number of scaffolds from 27 to 10 and increased the N50 
value from 511,891 to 848,093 bases. The hybrid assembly was then annotated using 
Prokka58 v.1.2. Filtered and cleansed RNA-seq reads were then aligned to this updated draft 
genome using Novoalign (reference indexed at k-mer length of 10 and step size of 1 using 
novoindex), resulting in average genome coverage of 16X. Rapaport et al59 and Liu et al60 
have recently shown that the accuracy of gene expression analysis algorithms is enhanced by 
the number of replicates used (2 or 3 replicates) rather than the coverage depth. Our RNA-
seq experiment utilizes 3-4 replicates; therefore, the accuracy of our differential gene 
expressions calls should be unaffected by the moderate (16X) coverage depth. Furthermore, 
MA plots (log2 fold change versus log2 mean normalized counts for each transcripts) show 
that there is no bias in our differential gene expression calls toward the high abundance 
transcripts (Supplementary Fig. 8). All alignments were sorted by name, indexed and stored 
in BAM format files. Gene count matrices were generated using htseq-count v.0.5.4p1 
(http://www-huber.embl.de/users/anders/HTSeq/doc/overview.html) along with the GTF file 
generated from the annotation step above. Differential gene expression was evaluated using 
edgeR (v.3.2.4)61 according to procedures described in the package’s user guide section 3.3 
(http://www.bioconductor.org/packages/2.12/bioc/html/edgeR.html). Briefly, a contrast 
matrix incorporating either the time-points (for the first RNA-seq experiment) or the 
genotype/disease groups and the time-points (for the second RNA-seq experiment) was 
generated for each of the comparisons: AOM/Il10−/− week 12 vs. day 2, AOM/Il10−/− week 
20 vs. day 2 and AOM/Il10−/− week12 vs. week 20 (first RNA-seq experiment) or AOM/
Il10−/− vs. Il10−/−, AOM/Il10−/− vs. AOM Il10−/−;Rag2−/− and Il10−/− vs. AOM 
Il10−/−;Rag2−/− (second RNA-seq experiment). Then this contrast matrix was used in gene-
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wise negative binomial generalized linear model (GLM) to test the null hypothesis that the 
contrast (as defined in the contrast matrix) of the coefficients is equal to zero. A gene was 
considered differentially expressed if its FDR corrected P-value was < 0.1. Genes were 
mapped to KEGG pathways using Pathview v. 1.1.724.
We performed operon prediction on the filtered and cleansed RNA-seq reads from the 
second RNA-seq experiment using Rockhopper v.1.2.162 (Rockhopper was utilized for the 
purpose of operon detection only). We used predicted operons with three or more genes and 
discarded the rest. Those predicted operons were then used for testing operon differential 
expression using GAGE v.2.12.063 along with the fitted counts from the GLM model of 
edgeR. All our differential expression analysis was done using edgeR (gene level) or GAGE 
(operon level). To ensure that the operon prediction algorithm did not unduly influence our 
results, we repeated our generation of operon P-values using a different assembly 
(Escherichia coli 536, NCBI GenBank accession NC_008253) and its predicted operons 
from the DOOR264 database. We saw broadly similar results with little pks differential 
expression at week 2, pks being one of the most up-regulated operons at week 12, and a 
decline in differential expression of pks at week 20 (Supplementary Fig 6). In determining 
P-values for Supplementary Fig 8, only the 3 animals for which we had RNA-seq data for 
all 3 time-points were used. We conclude that our results involving pks are not dependent on 
a particular assembly or operon prediction pipeline.
Analysis of the pks pathogenicity island
The pks island is composed of ~20 open reading frames spanning approximately 54 kb 18,65. 
It has been shown that the pks island of E. coli strain Nissle 1917 is organized into four 
polycistronic units: clbC to clbG, clbI to clbN, clbO to clbP and clbR to clbA based on RT-
PCR analysis50. In our de novo operon prediction, the pks island was organized into two 
polycistronic units: clbC to clbQ plus two open reading frames predicted as hypothetical 
proteins and clbR to clbA. When testing for operon differential expression (see above), we 
ran three analyses; the first using the four polycistronic units from Homburg et al50,the 
second using the two polycistronic units from Rockhopper predictions and the third using 
the pks of Escherichia coli 536 as predicted by the DOOR2 database.
Statistics
Statistical tests are described in figure legends and were computed using PRIMER v. 6, 
Microsoft Excel, Graphpad Prism, R v.3.0.1 and v.3.0.2 (http://www.R-project.org), and/or 
SAS v. 9.2 and v.9.3 (SAS Institute Inc., Cary, NC). Inflammation, tumorigenesis scoring, 
and qPCR results (Fig. 4) were compared between groups using Kruskal-Wallis with Dunn’s 
test for multiple comparisons. These tests are two-tailed, alpha=0.05. We controlled for false 
discovery rate (FDR) by correcting the P-values using Benjamini and Hochberg (BH) 
approach66 where applicable.
Our mixed linear model, in which genotype and time is a fixed effect and cage is a random 
effect23, takes the form of:
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where Yijkl represents either PCoA axis value, phylum count, family count, genus count, 
OTU count or richness value for Genotype i, Time j, Cage k and replicate l. Gi.is the effect 
of the ith genotype, were Genotype is set to either WT or Il10−/−. Tj is effect from the jth 
time point. (GT)ij is the interaction effect between genotype i and time j. Ck(i) is the effect 
from the kth cage that is nested within the ith genotype and εijkl denotes the error associated 
with measuring Yijkl.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Change in microbial community composition over time
a-c) Bray-Curtis Principal Coordinate Analysis (PCoA) at the operational taxonomic unit 
(OTU) level, with ANOSIM R and P-values nested on cage. Each symbol represents an 
individual mouse at the indicated time-point. d) Mixed linear model FDR corrected P-values 
for the first 10 coordinates of PCoA (explaining 58.4% of the variance) evaluating the null 
hypothesis that the fixed factor indicated above each plot does not impact the coordinate. 
Gray line represents P=0.05 significance level. e-f) Comparisons by the mixed linear model, 
Arthur et al. Page 19













with all comparisons and FDR corrected P values shown in (f). Il10−/− week 2 n=17, week 
12 n=16, week 20 n=15; WT week 2 n=24, week 12 n=22, week 20 n=24.
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Figure 2. Abundance of Enterobacteriaceae and Escherichia/Shigella
Increased abundance of (a) Enterobacteriaceae, and (b) OTU consensus 27 (Escherichia/
Shigella) in Il10−/− mice. Box and whisker plots show the minimum, first quartile, median, 
third quartile and maximum relative abundance (showing the median of each cage). FDR 
corrected P values from the mixed linear model. Il10−/− week 2 n=17, week 12 n=16, week 
20 n=15; WT week 2 n=24, week 12 n=22, week 20 n=24.
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Figure 3. RNA-seq reveals changes to the E. coli transcriptome over time in AOM/Il10−/− mice
a) Principal Component Analysis plot constructed from the normalized E. coli gene counts 
from AOM/Il10−/− mice at all time points. Each symbol indicates an individual mouse at 
each time-point (white=day 2, grey=week 12, black=week 18). b) Number of differentially 
expressed genes (FDR corrected P-value < 0.1) in the top 5 most represented KEGG 
pathways. Positive values on y-axis represent genes up-regulated and negative values 
represent genes down-regulated relative to day 2 time-point.
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Figure 4. Inflammation is required for E. coli-enhanced tumorigenesis in Il10−/− mice
Histologic scoring of (a) inflammation and (b) tumorigenesis. c) Representative H&E 
histology at 40X magnification, scale bars indicate 1.0mm, and neoplastic lesion indicated 
with arrowhead. d) Luminal E. coli load by qPCR of fecal genomic DNA. (a, b, d) Each 
symbol represents an individual mouse, line at mean, P-values by Kruskal-Wallis with 
Dunn’s test for multiple comparisons.
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Figure 5. Microbial adaptation to the mammalian intestine drives E. coli transcriptional changes 
over time
a) Timeline of sample collection. b) Principal Component Analysis plot constructed from 
the normalized E. coli gene counts from all samples and time points. Each symbol indicates 
an individual mouse at each time-point (white=week 2, grey=week12, black=week 20). 
Shape indicates genotype/disease: circle=AOM/Il10−/− n=4 (20 weeks n=3), 
triangle=Il10−/− n=4, square=AOM/Il10−/−;Rag2−/− n=4. c-d) Venn diagrams of 
differential expression (FDR corrected P<0.10) in c) AOM/Il10−/−;Rag2−/− vs. AOM/
Il10−/− or Il10−/− (inflammation), d) AOM/Il10−/− vs. Il10−/− (cancer).
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